Dynavax Technologies Corp. (DVAX) Commences Phase 1b Clinical Trial of Universal Flu Vaccine in Collaboration with Novartis
Dynavax Technologies Corp., a clinical-stage biopharmaceutical company, today announced it has begun to immunize patients in a phase 1b clinical…